The joint CiM-IMPRS graduate program of the International Max Planck Research School - Molecular Biomedicine and Münster’s Cells in Motion Interfaculty Centre offers positions to pursue PhD projects in the areas of biology, chemistry, physics, mathematics or computer science. We are looking for young scientists with a vivid interest in interdisciplinary projects to image cell dynamics from the subcellular to the patient level. PhD projects range from the analysis of basic cellular processes to clinical translation, from the application of novel biophysical approaches and the generation of mathematical models to the development of new imaging-related techniques and compounds.
- Cell and Molecular Biology
- Developmental and Stem Cell Biology
- Vascular Biology
- In vivo Imaging
- High Resolution Optical Imaging
- Chemical Biology
- Label Chemistry
- Mathematical Modelling
Applications for the PhD program can be submitted from 10 February to 4 April 2021. Projects start in October 2021 (earlier starts are possible if desired). Applications can only be submitted via our online system.
We offer 16 fully financed PhD positions. More positions financed by work contracts may be offered depending on availability. Excellent scientific and transferable skills trainings, competitive work contracts or tax-free fellowships as well as support with administrative matters, accommodation, and visas are part of the program. There are no tuition fees. The program language is English.
The Max Planck Society is committed to increasing the number of individuals with disabilities in its workforce and therefore encourages applications from such qualified individuals. Furthermore, the Max Planck Society seeks to increase the number of women in those areas where they are underrepresented and therefore explicitly encourages women to apply.
We invite applications from highly qualified and motivated students of any nationality from biological sciences, chemistry, mathematics, computer sciences and physics. Be part of CiM-IMPRS, a program run jointly by the University of Münster and the Max Planck Institute for Molecular Biomedicine.
For more information click "LINK TO ORIGINAL" below.